seventy patients with stage i and ii malignant melanoma were randomized to treatment with either intravenous dacarbazine alone or intravenous dacarbazine plus intradermal injection of the methanol-extracted residue of bacillus calmette-guerin ( bcg ) .
C0025202
malignant melanoma
C0010927
dacarbazine